Optimal tacrolimus levels for reducing CKD risk and the impact of intrapatient variability on CKD and ESRD development following liver transplantation

Optimal tacrolimus levels for reducing CKD risk and the impact of intrapatient variability on CKD and ESRD development following liver transplantation

Background/Aims This study aimed to identify the risk factors for chronic kidney disease (CKD) and end-stage renal disease (ESRD) following liver transplantation (LT), with a specific focus on tacrolimus levels and intrapatient variability (IPV). Methods Among the 1,076 patients who underwent LT bet...

Full description

Saved in:
Bibliographic Details
Main Authors: Soon Kyu Lee, Ho Joong Choi, Young Kyoung You, Pil Soo Sung, Seung Kew Yoon, Jeong Won Jang, Jong Young Choi
Format: Article
Language:English
Published: Korean Association for the Study of the Liver 2025-01-01
Series:Clinical and Molecular Hepatology
Subjects:
liver transplantation
chronic kidney disease
tacrolimus
tenofovir
diabetes mellitus
Online Access:http://e-cmh.org/upload/pdf/cmh-2024-0451.pdf
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

http://e-cmh.org/upload/pdf/cmh-2024-0451.pdf

Similar Items